Alzheimer risk factors age and female sex induce cortical Aβ aggregation by raising extracellular zinc

[1]  Li Liu,et al.  Zinc transporters in Alzheimer’s disease , 2019, Molecular Brain.

[2]  A. Palmer,et al.  Intracellular Zn2+ transients modulate global gene expression in dissociated rat hippocampal neurons , 2019, Scientific Reports.

[3]  L. Schmued,et al.  High Contrast and Resolution Labeling of Amyloid Plaques in Tissue Sections from APP-PS1 Mice and Humans with Alzheimer’s Disease with the Zinc Chelator HQ-O: Practical and Theoretical Considerations , 2019, Current Alzheimer research.

[4]  A. Bush,et al.  Difference in ability for extracellular Zn2+ influx between human and rat amyloid β1-42 and its significance. , 2019, Neurotoxicology.

[5]  Benjamin A. Logsdon,et al.  Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age , 2019, Nature Communications.

[6]  A. Bush,et al.  Treating Alzheimer's disease by targeting iron , 2019, British journal of pharmacology.

[7]  J. Schneider,et al.  Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology , 2019, Molecular Psychiatry.

[8]  T. Kambe,et al.  Zinc Transporter Proteins: A Review and a New View from Biochemistry , 2019, Zinc Signaling.

[9]  A. Bush,et al.  Targeting metals rescues the phenotype in an animal model of tauopathy. , 2018, Metallomics : integrated biometal science.

[10]  E. Gouaux,et al.  Mechanisms for Zinc and Proton Inhibition of the GluN1/GluN2A NMDA Receptor , 2018, Cell.

[11]  C. Ballard,et al.  Associations between ZnT3, tau pathology, agitation, and delusions in dementia , 2018, International journal of geriatric psychiatry.

[12]  Imane Lejri,et al.  Mitochondria, Estrogen and Female Brain Aging , 2018, Front. Aging Neurosci..

[13]  Yun-Ru Chen,et al.  Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease , 2018, Scientific Reports.

[14]  C. Rowe,et al.  A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study , 2017, Alzheimer's & dementia.

[15]  A. Bush,et al.  Extracellular Zn2+ Is Essential for Amyloid β1–42-Induced Cognitive Decline in the Normal Brain and Its Rescue , 2017, The Journal of Neuroscience.

[16]  Joana S. Ferreira,et al.  Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses , 2017, eLife.

[17]  A. Bush,et al.  Metal chaperones prevent zinc-mediated cognitive decline , 2015, Neurobiology of Disease.

[18]  S. Lippard,et al.  Modulation of extrasynaptic NMDA receptors by synaptic and tonic zinc , 2015, Proceedings of the National Academy of Sciences.

[19]  D. Aarsland,et al.  Depression and synaptic zinc regulation in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia. , 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[20]  A. Bush,et al.  Amyloid β-Mediated Zn2+ Influx into Dentate Granule Cells Transiently Induces a Short-Term Cognitive Deficit , 2014, PloS one.

[21]  Alan J. Thomas,et al.  Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment , 2014, Neurobiology of Aging.

[22]  A. Bush,et al.  A novel approach to rapidly prevent age-related cognitive decline , 2013, Aging cell.

[23]  H. Gábor.  Physiological factors could enhance amyloid-beta toxicity , 2013 .

[24]  Á. Hunya,et al.  A novel method for the rapid determination of beta-amyloid toxicity on acute hippocampal slices using MTT and LDH assays , 2012, Brain Research Bulletin.

[25]  J. Hwang,et al.  Alteration of the Cerebral Zinc Pool in a Mouse Model of Alzheimer Disease , 2012, Journal of neuropathology and experimental neurology.

[26]  R. Palmiter,et al.  Dependence of the histofluorescently reactive zinc pool on zinc transporter-3 in the normal brain , 2011, Brain Research.

[27]  Á. Hunya,et al.  A novel application of the fluorescent dye bis-ANS for labeling neurons in acute brain slices , 2011, Brain Research Bulletin.

[28]  J. Buxbaum,et al.  Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold , 2011, Molecular Neurodegeneration.

[29]  A. Bush,et al.  Presenilins Promote the Cellular Uptake of Copper and Zinc and Maintain Copper Chaperone of SOD1-dependent Copper/Zinc Superoxide Dismutase Activity* , 2011, The Journal of Biological Chemistry.

[30]  K. Blennow,et al.  PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. , 2010, Journal of Alzheimer's disease : JAD.

[31]  A. Bush,et al.  Cognitive Loss in Zinc Transporter-3 Knock-Out Mice: A Phenocopy for the Synaptic and Memory Deficits of Alzheimer's Disease? , 2010, The Journal of Neuroscience.

[32]  J. Hellemans,et al.  ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain , 2009, Molecular Neurodegeneration.

[33]  A. Bush,et al.  Zinc in the physiology and pathology of the CNS , 2009, Nature Reviews Neuroscience.

[34]  R. Metherate,et al.  A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses , 2009, The Journal of Neuroscience.

[35]  K. Blennow,et al.  Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial , 2008, The Lancet Neurology.

[36]  C. Shuttleworth,et al.  Zn2+ Influx Is Critical for Some Forms of Spreading Depression in Brain Slices , 2008, The Journal of Neuroscience.

[37]  C. Masters,et al.  Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ , 2008, Neuron.

[38]  Charles P. Fontaine,et al.  Insights into Zn2+ homeostasis in neurons from experimental and modeling studies. , 2008, American journal of physiology. Cell physiology.

[39]  M. Stoltenberg,et al.  Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency , 2007, Neuroscience.

[40]  Á. Hunya,et al.  A novel and simple fluorescence method for the measurement of presynaptic vesicular zinc release in acute hippocampal slices with a fluorescence plate reader , 2007, Brain Research Bulletin.

[41]  E. Krause,et al.  Depsipeptide methodology for solid-phase peptide synthesis: circumventing side reactions and development of an automated technique via depsidipeptide units. , 2006, The Journal of organic chemistry.

[42]  Yaping Zeng,et al.  Synaptic release of zinc from brain slices: Factors governing release, imaging, and accurate calculation of concentration , 2006, Journal of Neuroscience Methods.

[43]  L. Juliano,et al.  Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. , 2005, The Journal of biological chemistry.

[44]  Y. Kiso,et al.  The ‘O‐acyl isopeptide method’ for the synthesis of difficult sequence‐containing peptides: application to the synthesis of Alzheimer's disease‐related amyloid β peptide (Aβ) 1–42 , 2005, Journal of peptide science : an official publication of the European Peptide Society.

[45]  J. Troncoso,et al.  Immersion autometallographic tracing of zinc ions in Alzheimer beta-amyloid plaques , 2005, Histochemistry and Cell Biology.

[46]  A. Bush,et al.  The neurobiology of zinc in health and disease , 2005, Nature Reviews Neuroscience.

[47]  A. Craig,et al.  NMDA Receptor Activation Mediates Copper Homeostasis in Hippocampal Neurons , 2005, The Journal of Neuroscience.

[48]  M. Bennett,et al.  Late Calcium EDTA Rescues Hippocampal CA1 Neurons from Global Ischemia-Induced Death , 2004, The Journal of Neuroscience.

[49]  J. Koh,et al.  The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice , 2004, Neurobiology of Aging.

[50]  H. Braak,et al.  The Biphasic Relationship between Regional Brain Senile Plaque and Neurofibrillary Tangle Distributions: Modification by Age, Sex, and APOE Polymorphism , 2004, Annals of the New York Academy of Sciences.

[51]  R. Palmiter,et al.  Neuronal Zinc Exchange with the Blood Vessel Wall Promotes Cerebral Amyloid Angiopathy in an Animal Model of Alzheimer's Disease , 2004, The Journal of Neuroscience.

[52]  R. Palmiter,et al.  Estrogen Decreases Zinc Transporter 3 Expression and Synaptic Vesicle Zinc Levels in Mouse Brain* , 2004, Journal of Biological Chemistry.

[53]  A. Mackinnon,et al.  Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.

[54]  D. Holtzman,et al.  In Vivo Assessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-Life , 2003, The Journal of Neuroscience.

[55]  C. Finch,et al.  Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[57]  H. Levine.  4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonate: report on non-β-sheet conformers of Alzheimer's peptide β(1-40) , 2002 .

[58]  Jae-Young Koh,et al.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[59]  H. Levine.  4,4(')-Dianilino-1,1(')-binaphthyl-5,5(')-disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta(1-40). , 2002, Archives of biochemistry and biophysics.

[60]  J. Sarvey,et al.  Induction of Mossy Fiber→CA3 Long-Term Potentiation Requires Translocation of Synaptically Released Zn2+ , 2001, The Journal of Neuroscience.

[61]  C. Masters,et al.  Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.

[62]  F. Bian,et al.  Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. , 2001, The American journal of pathology.

[63]  Xudong Huang,et al.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.

[64]  C. Ackerley,et al.  Endogenous Zn2+ is required for the induction of long‐term potentiation at rat hippocampal mossy fiber‐CA3 synapses , 2000, Synapse.

[65]  Xudong Huang,et al.  Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* , 2000, The Journal of Biological Chemistry.

[66]  R. Colvin,et al.  Zinc transport in the brain: routes of zinc influx and efflux in neurons. , 2000, The Journal of nutrition.

[67]  Sang Won Suh,et al.  Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains , 2000, Brain Research.

[68]  M. Smith,et al.  Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. , 2000, The Journal of biological chemistry.

[69]  C. Masters,et al.  Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* , 1999, The Journal of Biological Chemistry.

[70]  C. Barrow,et al.  Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease. , 1999, Biochemistry.

[71]  Jae-Young Koh,et al.  Histochemically Reactive Zinc in Plaques of the Swedish Mutant β-Amyloid Precursor Protein Transgenic Mice , 1999, The Journal of Neuroscience.

[72]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[73]  Xudong Huang,et al.  Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.

[74]  Yong Y. He,et al.  The Role of Zinc in Selective Neuronal Death After Transient Global Cerebral Ischemia , 1996, Science.

[75]  T. J. Teyler,et al.  Making the best of brain slices; comparing preparative methods , 1995, Journal of Neuroscience Methods.

[76]  R. Palmiter,et al.  Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. , 1995, The EMBO journal.

[77]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[78]  M. Mattson,et al.  Growth Factors Prevent Mitochondrial Dysfunction, Loss of Calcium Homeostasis, and Cell Injury, but Not ATP Depletion in Hippocampal Neurons Deprived of Glucose , 1993, Experimental Neurology.

[79]  M. Mayer,et al.  The action of zinc on synaptic transmission and neuronal excitability in cultures of mouse hippocampus. , 1989, The Journal of physiology.

[80]  R. Martins,et al.  A4 amyloid protein deposition and the diagnosis of Alzheimer's disease , 1988, Neurology.

[81]  D. Choi,et al.  Zinc neurotoxicity in cortical cell culture , 1988, Neuroscience.

[82]  M. Mayer,et al.  Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons , 1987, Nature.

[83]  C. Cotman,et al.  Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease , 1986, Brain Research.

[84]  G. A. Howell,et al.  Stimulation-induced uptake and release of zinc in hippocampal slices , 1984, Nature.